SEC Filing Update: #KPTI Karyopharm Therapeutics Inc. : $1.79

Sector: Healthcare | YTD: 🔽 -75.31% The SEC disclosed Today (04-SEP-2026) that INTEGRATED CORE STRATEGIES (US) has INCREASED #KPTI Shares by 205.98% 🟢 * Previous Holdings: 423.98K Shares * Current Holdings: 1.30M Shares * Increase+873.32K * Increased(%)+205.98% * Ownership: 5.7% * Estimated Investment Value: $1.64M https://www.thinksabio.com/reports/isr/KPTI Institutional ownership in #KPTI has been steadily rising over the past 4 quarters in Shares: Q3 2025: 2.98M Q4 2025: 9.47M Q1 2026: 17.67M Q2 2026: 19.80M 📌 Institutional activity in the last 30 days for #KPTI: • GOLDMAN SACHS GROUP INC – Increased holdings by 437,834 shares (11-AUG-2026) • RA CAPITAL MANAGEMENT – Increased holdings by 223,591 shares (14-AUG-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2095993022748021128 INTEGRATED CORE STRATEGIES (US) increased its shareholding in KPTI from 423,982 shares to 1,297,297 shares, representing 5.7% ownership.